p202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells

Biochemical and Biophysical Research Communications

Volumn 303, Issue 1, 2003, Pages 219-222

  Yan, Duen Hwa ^a,b   Abramian, Aram ^a   Li, Zheng ^a   Ding, Yi ^a   Wen, Yong ^a,b   Liu, Ta Jen ^a,b   Hunt, Kelly ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERFERON; PROTEIN; PROTEIN P202; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; CARRIER PROTEIN; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL PEPTIDE; TP53BP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; FLOW CYTOMETRY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TIME; TRANSACTIVATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASE 3; CASPASES; CELL CYCLE PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0037470832     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00320-6     Document Type: Article

References (18)

1. Lengyel P., Choubey D., Li S.-J., Datta B. The interferon-activatable gene 200 cluster: from structure toward function. Sem. Virol. 6:1995;203-213.
2. Landolfo S., Gariglio M., Gribaudo G., Lembo D. The Ifi 200 genes: an emerging family of IFN-inducible genes. Biochimie. 80:1998;721-728.
3. Johnstone R.W., Trapani J.A. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol. Cell. Biol. 19:1999;5833-5838.
4. Choubey D. P202: an interferon-inducible negative regulator of cell growth. J. Biol. Regul. Homeost. Agents. 14:2000;187-192.
5. Qin X.Q., Livingston D.M., Kaelin W.G. Jr., Adams P.D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;10918-10922.
6. Hunt K.K., Deng J., Liu T.J., Wilson-Heiner M., Swisher S.G., Clayman G., Hung M.C. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res. 57:1997;4722-4726.
7. Shan B., Farmer A.A., Lee W.H. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis. Cell Growth Differ. 7:1996;689-697.
8. Kowalik T.F., DeGregori J., Schwarz J.K., Nevins J.R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69:1995;2491-2500.
9. Choubey D., Li S.-J., Datta B., Gutterman J.U., Lengyel P. Inhibition of E2F-mediated transcription by p202. EMBO J. 15:1996;5668-5678.
10. Kaighn M.E., Shankar N., Ohnuki Y., Lechner J.F., Jones L.W. Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest. Urol. 17:1979;16-23.
11. Yan D.-H., Wen Y., Spohn B., Choubey D., Gutterman J.U., Hung M.-C. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene. 18:1999;807-811.
12. Ding Y., Wen Y., Spohn B., Wang L., Xia W., Kwong K.Y., Shao R., Li Z., Hortobagyi G.N., Hung M.-C., Yan D.-H. Pro-apoptotic and anti-tumor activities of adenovirus-mediated p202 gene transfer. Clin. Cancer Res. 8:2002;3290-3297.
13. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
14. Nahle Z., Polakoff J., Davuluri R.V., McCurrach M.E., Jacobson M.D., Narita M., Zhang M.Q., Lazebnik Y., Bar-sagi D., Lowe S.W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4:2002;859-864.
15. Wang H., Liu C., Lu Y., Chatterjee G., Ma X.Y., Eisenman R.N., Lengyel P. The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-myc by blocking its association with max. J. Biol. Chem. 275:2000;27377-27385.
16. D'Souza S., Xin H., Walter S., Choubey D. The gene encoding p202 an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J. Biol. Chem. 276:2001;298-305.
17. Datta B., Li B., Choubey D., Nallur G., Lengyel P. p202 an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J. Biol. Chem. 271:1996;27544-27555.
18. Wen Y., Yan D.H., Spohn B., Deng J., Lin S.Y., Hung M.C. Tumor suppression and sensitization to tumor necrosis factor α-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells. Cancer Res. 60:2000;42-46.